Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Role of the intestinal immune system in obesity-related insulin resistance
EF 2015-16
Résumé
Type 2 diabetes (T2D) and obesity are growing global health concerns with over 60 000 new cases in Canada each year. Obesity predisposes to a state of insulin resistance, which contributes to the development of T2D. Recent research has discovered links between the immune system, inflammation, and insulin resistance. The first part of my study found that a high fat diet induces inflammation in the small and large intestines of mice. We found that during a high fat diet, a higher number of white blood cells in the gut, specifically T cells, promote inflammation in both mice and humans and this weakens the gut wall. With a more permeable gut, unwanted bacterial or food components leak through and increase inflammation in the gut and fat tissue. To tackle this inflammation, we have successfully used a gut-specific anti-inflammatory drug, known as mesalamine, to reduce gut inflammation and improve subsequent fat tissue inflammation and metabolic disease. However, more research is required to fully understand how our gut-specific therapy works and how other types of gut immune cells are affected by obesity.
This research proposal aims to define the changes to the gut immune system, specifically anti-inflammatory immune cells, in the development of T2D. Our last study found that mesalamine increases anti-inflammatory regulatory T cells in the gut, which were initially decreased by high fat diet feeding. To continue this research, we will analyze the effect of high fat diet on several anti-inflammatory immune cell types in mice and humans, specifically those that help tolerate food and commensal bacteria encountered in the gut. Next, we will determine the mechanism by which these anti-inflammatory cell types improve metabolic dysfunction in order to help us develop potential therapies for this disease. Together, our research will advance the understanding of diabetes from the viewpoint of the gut immune system and suggest novel treatment options against this disease.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
347936
Name
Luck Helen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of the intestinal immune system in obesity-related insulin resistance
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Diet-Induced Obesity; Inflammation; Insulin Resistance; Intestinal Immune System; Type 2 Diabetes
Abstract
Type 2 diabetes (T2D) and obesity are growing global health concerns with over 60 000 new cases in Canada each year. Obesity predisposes to a state of insulin resistance, which contributes to the development of T2D. Recent research has discovered links between the immune system, inflammation, and insulin resistance. The first part of my study found that a high fat diet induces inflammation in the small and large intestines of mice. We found that during a high fat diet, a higher number of white blood cells in the gut, specifically T cells, promote inflammation in both mice and humans and this weakens the gut wall. With a more permeable gut, unwanted bacterial or food components leak through and increase inflammation in the gut and fat tissue. To tackle this inflammation, we have successfully used a gut-specific anti-inflammatory drug, known as mesalamine, to reduce gut inflammation and improve subsequent fat tissue inflammation and metabolic disease. However, more research is required to fully understand how our gut-specific therapy works and how other types of gut immune cells are affected by obesity.
This research proposal aims to define the changes to the gut immune system, specifically anti-inflammatory immune cells, in the development of T2D. Our last study found that mesalamine increases anti-inflammatory regulatory T cells in the gut, which were initially decreased by high fat diet feeding. To continue this research, we will analyze the effect of high fat diet on several anti-inflammatory immune cell types in mice and humans, specifically those that help tolerate food and commensal bacteria encountered in the gut. Next, we will determine the mechanism by which these anti-inflammatory cell types improve metabolic dysfunction in order to help us develop potential therapies for this disease. Together, our research will advance the understanding of diabetes from the viewpoint of the gut immune system and suggest novel treatment options against this disease.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Luck, Helen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~